Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Cabaletta Bio, Inc. CABA

Set alert

Price alert · CABA

All alert types
1.43 USD -0.08 -5.30%

At close · Nov 2

1.43 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
1.42 × 2
Ask
1.43 × 2
1.38 Day range 1.54
1.32 52-week range 4.23
YTD
-34.70%
1 year
-60.39%
Open
1.52
Prev close
1.51
Mkt cap
242.45M
Vol
5.69M
Avg vol
5.23M
EPS
-1.42
P/E
0.00
Div yield
0.00%
More statistics
Low
1.38
High
1.54
Forward P/E
-0.98
Beta
2.42
Short ratio
4.26
Inst. own
100.47%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
3.53
200-d avg
8.16
1y target
22.22

3M chart

Chart tools
Interval
1m5m15m30m

Signals (11)
NameDateAgo
RSI: OversoldOct 23, 20261 week ago
MACD: Buy SignalOct 22, 20261 week ago
RSI: OversoldOct 12, 20263 weeks ago
RSI: OversoldSep 25, 20261 month ago
SMA: BearishSep 9, 20261 month ago
SMA: BearishSep 9, 20261 month ago
MACD: Sell SignalSep 9, 20261 month ago
RSI: OverboughtAug 27, 20262 months ago
SMA: BullishAug 17, 20262 months ago
SMA: BearishAug 13, 20262 months ago
SMA: BullishAug 12, 20262 months ago

Financial health

Altman Z-Score

-1.59 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 3

Valuation

P/E -1.3×
FY 2017: -962×FY 2018: -11.9×FY 2019: -3.4×FY 2020: -8.7×FY 2021: -2.1×FY 2022: -5.1×FY 2023: -13.8×FY 2024: -1.0×FY 2025: -1.3×
FY 2017 5y median -2.1× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 2.0×
FY 2017: -965×FY 2018: -13.6×FY 2019: 0.4×FY 2020: 2.6×FY 2021: 0.8×FY 2022: 2.6×FY 2023: 3.9×FY 2024: 0.7×FY 2025: 2.0×
FY 2017 5y median 2.0× FY 2025
P/FCF -1.7×
FY 2017: 0.0×FY 2018: -31.1×FY 2019: -3.5×FY 2020: -10.5×FY 2021: -2.8×FY 2022: -5.6×FY 2023: -17.1×FY 2024: -1.2×FY 2025: -1.7×
FY 2017 5y median -2.8× FY 2025
EV/EBITDA -1.0×
FY 2017: 2884×FY 2018: -26.0×FY 2019: 4.2×FY 2020: -5.7×FY 2021: 0.5×FY 2022: -3.8×FY 2023: -11.2×FY 2024: 0.3×FY 2025: -1.0×
FY 2017 5y median -1.0× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -59.1%
FY 2017: 0.0%FY 2018: -3.2%FY 2019: -28.8%FY 2020: -9.5%FY 2021: -36.2%FY 2022: -18.0%FY 2023: -5.8%FY 2024: -80.5%FY 2025: -59.1%
FY 2017 5y median -36.2% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -149.8%
FY 2017: 100.4%FY 2018: 114.1%FY 2019: -12.2%FY 2020: -30.4%FY 2021: -39.2%FY 2022: -50.7%FY 2023: -28.7%FY 2024: -76.1%FY 2025: -149.8%
FY 2017 5y median -50.7% FY 2025
ROIC -123.8%
FY 2017: 100.4%FY 2018: -18.6%FY 2019: -13.5%FY 2020: -30.9%FY 2021: -39.3%FY 2022: -49.4%FY 2023: -31.0%FY 2024: -72.8%FY 2025: -123.8%
FY 2017 5y median -49.4% FY 2025
ROA -101.7%
FY 2017: -25000.0%FY 2018: -35.7%FY 2019: -12.0%FY 2020: -29.1%FY 2021: -36.6%FY 2022: -45.3%FY 2023: -26.7%FY 2024: -62.6%FY 2025: -101.7%
FY 2017 5y median -45.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income -37.6%
FY 2017: 0.0%FY 2018: -2377.2%FY 2019: -201.7%FY 2020: -81.1%FY 2021: -36.9%FY 2022: -16.9%FY 2023: -37.9%FY 2024: -67.6%FY 2025: -37.6%
FY 2017 FY 2025
EPS (diluted) 29.9%
FY 2017: 0.0%FY 2018: -7976.9%FY 2019: -384.5%FY 2020: 64.6%FY 2021: -25.0%FY 2022: -0.6%FY 2023: 8.8%FY 2024: -41.8%FY 2025: 29.9%
FY 2017 FY 2025
Free Cash Flow -46.3%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -259.1%FY 2020: -63.7%FY 2021: -28.7%FY 2022: -38.4%FY 2023: -11.1%FY 2024: -66.7%FY 2025: -46.3%
FY 2017 FY 2025

Financial Health

Current Ratio 2.8×
FY 2017: 0.0×FY 2018: 36.0×FY 2019: 44.7×FY 2020: 21.9×FY 2021: 14.9×FY 2022: 11.5×FY 2023: 15.3×FY 2024: 6.2×FY 2025: 2.8×
FY 2017 5y median 11.5× FY 2025
Quick Ratio 2.8×
FY 2017: 0.0×FY 2018: 36.0×FY 2019: 44.7×FY 2020: 21.9×FY 2021: 14.9×FY 2022: 11.5×FY 2023: 15.3×FY 2024: 6.2×FY 2025: 2.8×
FY 2017 5y median 11.5× FY 2025
Debt / Equity 0.2×
FY 2017: 0.0×FY 2018: -4.1×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.2×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2017: -0.0×FY 2018: -1.8×FY 2019: 7.3×FY 2020: 3.1×FY 2021: 2.7×FY 2022: 1.5×FY 2023: 2.8×FY 2024: 1.3×FY 2025: 0.3×
FY 2017 5y median 1.5× FY 2025
Interest Coverage -85.9×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -167×FY 2025: -85.9×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 17.4%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -59.6%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31